16 July 2012 | News | By BioSpectrum Bureau
Misonix signs agreement with Seoul-based Soelim
Singapore: Misonix, a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has entered into a new three-year exclusive distribution agreement with Soelim, based in Seoul, South Korea. The agreement is for the distribution of SonaStar Ultrasonic Surgical Aspiration System and the BoneScalpel Ultrasonic Bone Cutting System.
The agreement provides Soelim with the right to sell throughout Korea. Included in the agreement are annual minimum purchase requirements. Registration and initial product training are complete and open market sales have begun.
Soelim is recognized as a premier distributor in South Korea with close to 25 years of experience introducing new, state-of-the-art products to their marketplace. They are well established in spine surgery, neurosurgery and other skull-based surgeries and have earned a reputation for providing a high level of service to their customer base. Their commitment to product support and education is consistent with the Company's core values.
The SonaStar is used by neurosurgeons and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels and other surrounding tissue. OsteoSculptTM bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of safely making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps. The Product is used by neurosurgeons, cranio-maxillofacial surgeons and orthopedic surgeons for a wide range of procedures.
"We are quite pleased to add Soelim to our distribution organization in Asia; they represent a large and growing medical market and their presence should add measurably to our sales success. Their reputation for successfully introducing new products into the South Korean market is second to none," said Mr Michael A McManus, Jr., president and chief executive officer of Misonix. "We are particularly pleased that they will be selling two of our key products to the South Korean market."